Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
185.40
+3.39 (1.86%)
At close: Mar 9, 2026, 4:00 PM EDT
185.41
+0.01 (0.01%)
After-hours: Mar 9, 2026, 7:51 PM EDT
Jazz Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -356.15 | 560.12 | 414.83 | -224.06 | -329.67 | Upgrade
|
| Depreciation & Amortization | 696.3 | 660.07 | 638.7 | 629.47 | 552.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 37.7 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 947.86 | 10 | 80.01 | 577.8 | - | Upgrade
|
| Stock-Based Compensation | 291.13 | 248.05 | 226.84 | 222 | 189.01 | Upgrade
|
| Provision & Write-off of Bad Debts | 19.11 | 27.76 | 11.11 | 14.54 | 19.67 | Upgrade
|
| Other Operating Activities | -261.38 | -33.36 | -75.05 | 4.63 | 394.97 | Upgrade
|
| Change in Accounts Receivable | -106.28 | -21.12 | -51.88 | -90.14 | -92.74 | Upgrade
|
| Change in Inventory | -86.04 | -45.54 | -13.42 | -49.64 | -48.86 | Upgrade
|
| Change in Accounts Payable | 39.85 | -20.07 | 9.6 | -11.23 | 57.02 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -2.09 | -2.31 | Upgrade
|
| Change in Income Taxes | 37.22 | -14.74 | 25.22 | -1.69 | -15.52 | Upgrade
|
| Change in Other Net Operating Assets | 134.14 | 24.75 | -173.96 | 164.69 | 54.45 | Upgrade
|
| Operating Cash Flow | 1,356 | 1,396 | 1,092 | 1,272 | 778.51 | Upgrade
|
| Operating Cash Flow Growth | -2.88% | 27.83% | -14.15% | 63.39% | -13.46% | Upgrade
|
| Capital Expenditures | -58.75 | -38.07 | -23.96 | -29.05 | -27.64 | Upgrade
|
| Sale of Property, Plant & Equipment | 28.17 | - | - | - | - | Upgrade
|
| Cash Acquisitions | -858.05 | - | - | - | -6,235 | Upgrade
|
| Divestitures | - | - | - | 53 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -151 | -10 | -19 | -469.15 | -17.89 | Upgrade
|
| Investment in Securities | -470.28 | -460.13 | -120.1 | -1.04 | 1,068 | Upgrade
|
| Investing Cash Flow | -1,510 | -508.2 | -163.06 | -446.23 | -5,212 | Upgrade
|
| Long-Term Debt Issued | - | 980.77 | - | - | 5,191 | Upgrade
|
| Total Debt Issued | - | 980.77 | - | - | 5,191 | Upgrade
|
| Long-Term Debt Repaid | -781 | -606 | -31 | -582.01 | -1,321 | Upgrade
|
| Total Debt Repaid | -781 | -606 | -31 | -582.01 | -1,321 | Upgrade
|
| Net Debt Issued (Repaid) | -781 | 374.77 | -31 | -582.01 | 3,871 | Upgrade
|
| Issuance of Common Stock | 107.86 | 20.65 | 46.46 | 98.02 | 135.26 | Upgrade
|
| Repurchase of Common Stock | -200.24 | -369.18 | -320.71 | -45.5 | -35.6 | Upgrade
|
| Other Financing Activities | - | -5.72 | - | - | - | Upgrade
|
| Financing Cash Flow | -873.38 | 20.52 | -305.25 | -529.49 | 3,971 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.56 | -1.68 | 1.14 | -6.22 | -3.21 | Upgrade
|
| Net Cash Flow | -1,021 | 906.55 | 624.83 | 290.03 | -466.32 | Upgrade
|
| Free Cash Flow | 1,297 | 1,358 | 1,068 | 1,243 | 750.87 | Upgrade
|
| Free Cash Flow Growth | -4.48% | 27.13% | -14.07% | 65.53% | -15.12% | Upgrade
|
| Free Cash Flow Margin | 30.39% | 33.37% | 27.86% | 33.97% | 24.27% | Upgrade
|
| Free Cash Flow Per Share | 21.27 | 20.57 | 14.82 | 19.87 | 12.58 | Upgrade
|
| Cash Interest Paid | 248.55 | 314.82 | 333.11 | 270.67 | 138.27 | Upgrade
|
| Cash Income Tax Paid | 121.81 | 114.91 | 177.88 | 94.68 | 271.22 | Upgrade
|
| Levered Free Cash Flow | 1,336 | 1,436 | 1,056 | 1,125 | -138.27 | Upgrade
|
| Unlevered Free Cash Flow | 1,512 | 1,651 | 1,278 | 1,312 | 37.09 | Upgrade
|
| Change in Working Capital | 18.9 | -76.72 | -204.44 | 9.91 | -47.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.